Description
Product Properties
|
Property Name |
Property Details |
|
Alternative Names |
CD8, MAL, Lyt-2, CD8a |
|
Species |
Human |
|
Expression Sequence |
Ser22-Asp182 |
|
Accession |
P01732-1 |
|
Tag |
C-His |
|
Expression System |
HEK293 |
|
Molecular Weight |
Predicted MW: 18.70 kDa → Glycosylation shifts to 28-35 kDa (SDS-PAGE) |
|
Purity |
>95% (SDS-PAGE) |
|
Endotoxin |
<1.0 EU/μg (LAL method) |
|
Formulation |
Lyophilized from 0.22 μm filtered PBS (pH 7.4) + 8% trehalose |
|
Appearance |
Lyophilized Powder |
|
Biological Activity |
[ELISA Data] Immobilized Human CD8 alpha, His Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Anti-CD8 Antibody, hFc Tag with the EC50 of 29.4ng/ml determined by ELISA. |
|
Reconstitution Method |
Centrifuge → Reconstitute with distilled water (>100 μg/mL) → Aliquot to avoid freeze-thaw |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Lyophilized powder: Store at -25 to -15°C; stable for 1 year upon receipt.
Reconstituted protein: Store under sterile conditions at -85 to -65°C; stable for 3 months.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.